vsportÌåÓýƽ̨

À´Ô´£ºÁ÷ÈË £¬×÷Õߣº £¬£º

ÚÀ £¬ÎÒ¸úÄ㽲࣠£¬×î½ü¿© £¬º£¿ÚË®ÁÆÆ·²èÕâ¸ö¹¤¾ßÂù¶àÈËÎÊÎÒ¡£ÌرðÊÇÍâµØÀ´¹ðÁÖµÄÅóÓÑ £¬Ìýµ½¡°Æ·²è¡±Á½¸ö×־;õµÃÊÇÆ·Üø¡¢ÅݲèÄÇЩÊ¡£ÆäʵÍêÈ«²»ÊÇÄǸöÒâ˼¿©£¡ÄãÏþµÃû £¬ÔÛ¹ðÁÖÈ˽²¡°Æ·²è¡± £¬ÄÇÊÇÓеãÌØÊâµÄ˵·¨ £¬¸úÆ·Üø²îÁËÊ®Íò°ËǧÀï¡£

Æ·²èÄØ £¬ÔÚ¹ðÁÖÌØ±ðÔÚº£¿ÚÕâЩµØ·½ £¬»ù±¾¾ÍÊÇȥˮÁƵêÏíÊÜЧÀ͵Ĵú³Æ¡£Äã½² £¬ÌýÆðÀ´ÓеãÈÆÄó £¬µ«ÆäʵÊÇÀϹðÁÖµÄÎÄ»¯ËõӰ࣡£Õâ¸öÂï £¬¸úÒÔǰ¹ðÁÖÈ˺ý²¾¿Éú»îÆ·ÖÊÓеãÏñ¡£¿©¸öµØ·½ÄØ £¬½²¾¿¾Í¶àÁË¡£ÎÒ½ñÌì¾Í¸øÄã°ÚµãÕæÕýµÄÃŵÀ³öÀ´£¡

¡°Æ·²è¡±µÄ¹æÔòºÍÃŵÀ £¬ÏþµÃÁ˲ÅÓÐȤ

¿©¸öÆ·²èÂï £¬ÄãÒªÏþµÃËüµÄ½²¾¿¡£Ò»°ãÈ¥º£¿ÚË®ÁÆÆ·²è࣠£¬²»ÊÇËæ±ã×ß½øÒ»¼Ò¾ÍËãÍêÊÂ࣡£Õâ¸öË®ÁƵ갡 £¬ÃÅÃæÓÐʱºò¿´ÆðÀ´ÆÕͨ £¬µ«ÀïÃæµÄЧÀÍÖÊÁ¿²î±ð¿É´óµÃºÜ¡£Äã½²ÊÇûÊÇ£¿ÏñÎÒÃǹðÁÖµÄÃ×·Û̯×ÓÒ»Ñù £¬ÃÅÃæÆÕͨ £¬µ«Â±Ë®Ã»µ÷ºÃ¾ÍÍêȫûζµÀ¡£

Ê×ÏÈÄØ £¬ºÃµÄÆ·²èµê £¬ËüЧÀÍÔ±µÄ̬¶ÈºÍÎäÒÕ £¬ÄÇÊÇÏàµ±ÖØÒªµÄ¡£¹ðÁÖÈ˽²¾¿Õâ¸ö £¬ÒªÈÃÄãÊæÊæ·þ·þ £¬ÏñÅݽÅÒ»ÑùůÐÄ¡£Äã¿É²»¿ÉËæ±ãÑ¡ £¬ÌرðÊǵÚÒ»´ÎÈ¥ £¬×îºÃÌýÀϹðÁÖµÄÍÆ¼ö¡£¿©¸öÂï £¬¸úÕÒÒ»¼ÒÕý×ÚµÄÈýÆ·ÍõÒ»Ñù £¬ÄãµÃÏþµÃÄĸöÊÇËíµÀµÄ¡£

͵͵¸æËßÄãࣣºÒªÑ¡ºÃµÄÆ·²èµêÄØ £¬×¢Òâ¿©Á½µã¡ª¡ªÒ»ÊÇ¿´µêÀïµÄÇé¿ö £¬½à¾»Õû½à¿Ï¶¨ÊǵÚһλ  £»¶þÊÇ¿´Ð§ÀÍÔ±µÄ̬¶È £¬ÈÈÇéÓÖ²»¹ý·Ö²ÅÊÇÕý×Ú¡  £ÁíÓп© £¬ÀϹðÁÖÒ»°ã»áÊÔÊÔµêÀïµÄÕÐÅÆÏîÄ¿ £¬¾­³£ÄÜ¿´³öµêµÄÕæÕýˮƽ¡£ Ïà¹ØÍ¼Æ¬

ÁíÓÐÂï £¬Æ·²èµÄʱ¼äÒ²Óн²¾¿¡£Ò»°ãÇé¿öÏ¿© £¬ÍíÉÏÈ¥ÊÇ×îºÃµÄ £¬°×ÌìÂï £¬ËäȻҲÐÐ £¬µ«×ܸÐÊÜûÄǸöÆø·Õ¡£Äã½²ÊÇûÊÇ£¿ÍíÉÏÄÇÖֵƹâÒ»´ò £¬ÒôÀÖÒ»·Å £¬Õû¸ö¾Í¸üÊæ·þÁË¡£

ÎÒÄêÇá×ÓÄÇ¿­ £¬Æ·²èÒ²ÊÇÓйÊʵÄ

£¨¿ÚÓïÌ壩°¥Ñ½ £¬ÄÇ¿­ÎÒ¸ÕÏþµÃÆ·²èÕâ¸öÊ £¬¾Í¾õµÃÂùºÃÆæà£¡£µÚÒ»´ÎÈ¥ÄØ £¬ÊÇÎÒÒ»¸öÅóÓÑ´øÆðÎҿ˵Ä¡£Ëû½² £¬Õâ¼ÒµêºÜµÍµ÷ £¬µ«Ð§ÀÍÂùºÃ¡£ÎҾ͸úÆð¿ËÁË¡£¿©¸öµêÄØ £¬ÔÚÏï×Óβ £¬ÄÇ¿­¿©Â·µÆ¶¼»è»Æ»ÆµÄ £¬ÎÒÐÄÀïÁíÓеã´òÍËÌùÄ¡£

Ïà¹ØÍ¼Æ¬

½á¹ûÒ»½øÈ¥¿© £¬ÍêÈ«·×ÆçÑù࣡£ÀïÃæ×°ÐÞÂùÓÐζµÀ £¬ÏñÄÇÖÖÀϹðÁÖÓͲèµêµÄ¸ÐÊÜ £¬Ä¾Í·×ÀÒÎ £¬Ç½ÉÏ»¹¹ÒÆðЩÀÏÕÕÆ¬¡£ÎÒÄÇ¿­Ñ¡Á˸ö»ù´¡µÄÏîÄ¿ £¬³öÀ´ºó¾Í¾õµÃÕû¸öÈËÏñÅݹýÎÂȪһÑùÇáËÉ¡£Äã½²ÊÇûÊÇ £¬¿©ÖÖÌåÑé £¬µÖµÃÉÏÒ»Í뱲˷۵ļÛֵࣣ¡

Ïà¹ØÍ¼Æ¬
Ïà¹ØÍ¼Æ¬

ºóÊÖÎÊÌâºÍ»Ø¸²

ÌýÍê¿© £¬Äã¿ÉÄÜ»áÎÊ£º¡°ÄǾ¿¾¹È¥Äĸöµê²Å¿¿Æ×°¡£¿¡±

ÎÒ¸úÄ㽲࣠£¬¿¿Æ×µÄµê×ÓÆäʵÂù¶à £¬ÌرðÊÇÔÚº£¿ÚÄÇ±ß £¬µ«ÄãÒ»¶¨ÒªÏÈÎÊÎÊÍâµØÈË £¬»òÕßÊÔÊÔ¿Ú±®¸ßµÄ¡£ÕÕÎÒ¿´À´à£ £¬µÚÒ»´Î¾Í±ðÂÒÑ¡ £¬Ñ¡¿©¸öÇé¿öºÃµÄ £¬ÄÄŹóÒ»µã¶¼ÖµµÃ¡£


±êÇ©

  • º£¿ÚË®ÁÆÆ·²è
  • ¹ðÁÖÍâµØÎÄ»¯
  • Éú»îÆ·ÖÊ
  • ÀϹðÁÖ¹ÊÊÂ
  • Æ·²è½²¾¿

¡¶ÄÏ´¨Æ·ÜøµÄµØ·½¡·

¾¡¹Ü»Æ½ðÈÔÊÇĦ¸ùÊ¿µ¤ÀûÊ×ÍÆµÄ´ó×ÚÉÌÆ· £¬µ«¸ÃÐÐҲǿµ÷ÁËÆäËû½ðÊôÊг¡µÄÇ¿ÊÆÌåÏÖ¡£

¡¶Î÷°²Áú·ï²è�ÂÛ̳¡·

Ĭɳ¶«ÒÑËø¶¨½ØÖÁ2030Äê´úÖÐÆÚ³¬700ÒÚÃÀÔªÉÌÒµ»úÔµ £¬ÄÚ²¿×ʲúÓëÍⲿÊÕ¹º¸÷Т¾´Ò»°ëÔö³¤¡£70%À´×Ô10¸öÖØ°õDZÁ¦ÏîÄ¿£¨¶àΪfirst-in-class·Ö×Ó£© £¬ÆäÖÐ4¸öÒÑÉÏÊлòÓÐÑôÐÔ III ÆÚÊý¾Ý £¬ÆäÓà 12-18 ¸öÔÂÄÚÍê³ÉÒªº¦ III ÆÚ¶ÁÊý £¬enlicitide Óë sac-TMT »ñ FDA ÓÅÏÈÉóÆÀȯ¡£

¡¶ÐìÖÝÃÃ×ÓÆ·ÜøÈº¡·

×îÐÂÒ»ÆÚ³¥¸¶ÄÜÁ¦±¨¸æÏÔʾ £¬ÖйúÌú½¨¡¢¶«³Ç¹ú×ʹ«Ë¾Îª¹úÈΰü¹Ü²¢ÁеÚÎå´ó¹É¶« £¬³Ö¹ÉÊýÁ¿Îª2Òڹɡ£

ÍøÕ¾µØÍ¼